A stellar Faculty of world leading experts will discuss evidence on clinical outcomes and mechanisms of action of bariatric/metabolic surgery and new device-based interventions with the overarching aim to craft an agenda of research priorities and health policy initiatives.

The DSS-II will develop new recommendations and guidelines for multimodality treatment of type 2 diabetes.

WHO SHOULD ATTEND?

This event is designed for professionals in the fields of endocrinology, diabetes, bariatric/metabolic surgery, cardiology, epidemiology, gastroenterology, internal medicine, family medicine, pharmacology, nutrition, basic science, public health, as well as allied health professionals, policy makers and scientists from pharmaceutical and medical device industries.